We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Eye Care

News · October 12, 2020

EURETINA 2020: Preliminary Real-World Results Suggest Switch From Aflibercept to Ranibizumab Due to Lack of Efficacy in Diabetic Macular Edema May Prove Beneficial

The ongoing PRECISE study will reveal the anatomical outcomes of eyes that are switched

PracticeUpdate Editorial Team

 

Further Reading